title: Tinzaparin as an antithrombotic: an overview.
abstract: Tinzaparin is a low molecular weight heparin which is given subcutaneously once daily without the need for laboratory monitoring. Already established as effective therapy for deep venous thrombosis, in November 1997 it became the first low molecular weight heparin to be licensed for the treatment of pulmonary embolism.
authors.affiliation: Department of Haematology, Birmingham Heartlands Hospital.
authors.forename: C D
authors.initials: CD
authors.lastname: Fegan
mesh_terms: D005343:Fibrinolytic Agents / Q000494:pharmacology / Q000627:therapeutic use*; D006495:Heparin, Low-Molecular-Weight / Q000494:pharmacology / Q000627:therapeutic use*; D006801:Humans; D007279:Injections, Subcutaneous; D011655:Pulmonary Embolism / Q000188:drug therapy*; D013924:Thrombophlebitis / Q000188:drug therapy*; D000078222:Tinzaparin
chemical_list: D005343:Fibrinolytic Agents; D006495:Heparin, Low-Molecular-Weight; D000078222:Tinzaparin